Lemborexant Clinical Trials

2 actively recruiting trials

▲ +1 trial since May 2026

Also known as: Dayvigo

Pipeline

Phase 2: 1Phase 4: 1

Top Sponsors

YangPan1
Unity Health Toronto1

Indications

Insomnia Comorbid to Psychiatric Disorder1
Motor Disorder1
Major Depressive Disorder (MDD)1
Parkinson's Disease1
Depression1

Other2 trials

Effects of Lemborexant on Motor-sleep Comorbidity in Parkinson's Disease

Phase 4

Lemborexant for the Treatment of Residual Insomnia in Major Depressive Disorder (MDD)

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.